| Product NDC: | 51079-608 |
| Proprietary Name: | Fenofibrate |
| Non Proprietary Name: | fenofibrate |
| Active Ingredient(s): | 145 mg/1 & nbsp; fenofibrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51079-608 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202856 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130610 |
| Package NDC: | 51079-608-20 |
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-608-20) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-608-01) |
| NDC Code | 51079-608-20 |
| Proprietary Name | Fenofibrate |
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-608-20) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-608-01) |
| Product NDC | 51079-608 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fenofibrate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130610 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | FENOFIBRATE |
| Strength Number | 145 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |